Entereg

U.S. FDA advisors set to review opioid constipation drugs
Yahoo/Reuters
Mon, 06/9/14 - 11:04 am
FDA
opioid-induced constipation
Salix
Relistor
Cubist Pharmaceuticals
Entereg
AstraZeneca
Nektar
Naloxegol
2013 FDA Drug Approval Calendar
TheStreet.com
Tue, 05/21/13 - 12:05 pm
drug approvals
GSK
Dolutegravir
Trametenib
Auxilium
Xiaflex
Delcath
Melblez
Seattle Genetics
Adcetris
Antares
Otrexup
Amag Pharmaceuticals
Feraheme
Cubist Pharmaceuticals
Entereg
Gilead
sofosbuvir
Amarin
Vascepa
Merck
suvorexant
Valeant Pharmaceuticals
efinaconazole
Depomed
Sefelsa
Zogenix
Zohydro
dabrafenib
tivozanib
Aveo Pharmaceuticals
Cubist Submits ENTEREG Supplemental NDA
Pipeline Review
Sat, 12/22/12 - 12:58 pm
Cubist Pharmaceuticals
Entereg
GI recovery
Cubist Submits ENTEREG Supplemental NDA
Yahoo
Fri, 12/21/12 - 10:52 am
Entereg
Cubist Pharmaceuticals
bowel resection
Cubist Pharmaceuticals: Promising Biotech For The Future
Seeking Alpha
Mon, 11/26/12 - 11:01 am
Cubist Pharmaceuticals
Teva
Entereg
Cubicin
Adolor buys back Entereg rights from GlaxoSmithKline
Bizjournals.com
Tue, 09/6/11 - 12:19 pm
GSK
Adolor
Entereg
Adolor to buy out GSK stake in Entereg
Bizjournals.com
Wed, 06/15/11 - 08:29 am
GSK
Entereg
Adolor
Adolor to cut 30 jobs as Entereg sales disappoint
Yahoo/AP
Fri, 07/16/10 - 09:12 am
Adolor
layoffs
Entereg
Adolor narrows 4Q loss as Entereg sales increase
Yahoo/AP
Thu, 02/25/10 - 10:12 am
Adolor
earnings
Entereg
Possible new use for Adolor drug abandoned
Bizjournals.com
Thu, 12/18/08 - 03:34 pm
Adolor
Entereg
GSK